TED · 517353-2025 · 2025-08-07

Cyprus – Medicinal products for the blood and blood-forming organs – Προσφορά για την προμήθεια "Reblozyl" ΔΔΧΔΠΔ.ΣΠΥΥ 14/2025-ΟΑΥ

Κύπρος – Φάρμακα για το αίμα, τα αιμοποιητικά όργανα – Προσφορά για την προμήθεια "Reblozyl" ΔΔΧΔΠΔ.ΣΠΥΥ 14/2025-ΟΑΥ

Buyer
Υπουργείο Υγείας
Cyprus · CYP · NUTS CY000
Category (CPV)
33621000
CPV 336xxx
Procedure
neg-wo-call can-standard
Currency
EUR

What this category covers

This notice is classified under the EU's Common Procurement Vocabulary in the medical equipments, pharmaceuticals and personal care products division. The CPV is a hierarchical eight-digit taxonomy used across every EU public-procurement notice so contracts can be searched, compared and analysed by sector regardless of the publication language.

TED — Tenders Electronic Daily — is the EU's official journal for public procurement. This notice is publication #517353 from the 2025 series; every contract above the EU thresholds (currently €143,000 for central-government supplies and services, €5.5M for works) must be advertised here.

This is a metadata summary. The full notice — including contract conditions, technical specs, attachments, and award outcome — lives on the official TED website.

Open notice on ted.europa.eu →

More tenders in Cyprus

see all →

Frequently asked questions

Who is the contracting authority?
The contracting authority is Υπουργείο Υγείας, based in Cyprus (NUTS region CY000).
What is the CPV category of this tender?
The main Common Procurement Vocabulary (CPV) code is 33621000, which corresponds to CPV 336xxx.
Which country does this tender relate to?
This tender was published by a contracting authority in Cyprus (CYP).
What procedure type is used?
This tender uses the neg-wo-call procedure (notice type: can-standard).
Where can I find the official tender notice?
The full official notice, including contract conditions, technical specifications, attachments and any award outcome, is published on TED — Tenders Electronic Daily — under publication 517353-2025.